GlassScriptPhysician profile
Tara Davis-Boyd
NPI 1033749643
$4,183.19
in general payments reported to CMS, 2019-2025
11 companies · $762 in 2025
The $762 reported for 2025 was more than what 75% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $371 · 2023: $2,137 · 2024: $913 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,670 · Travel and Lodging: $1,084 · Education: $57.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,670.16 |
| Travel and Lodging | $1,084.32 |
| Education | $57.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,028.72 | 2023-2025 | Spravato, Invega Sustenna |
| Abbvie INC. | $985.70 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $279.94 | 2022-2025 | |
| Axsome Therapeutics, INC. | $213.96 | 2023-2025 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $139.67 | 2023-2024 | Caplyta |
| Vanda Pharmaceuticals INC. | $137.25 | 2024 | Fanapt, Hetlioz |
| Otsuka America Pharmaceutical, INC. | $124.09 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Idorsia Pharmaceuticals US INC | $117.08 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $89.06 | 2024-2025 | Cobenfy |
| Corium, LLC | $48.92 | 2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $18.80 | 2023 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Davis-Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.